azomycin has been researched along with lychnopholide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Branquinho, RT; de Lana, M; de Oliveira-Silva, JC; Mosqueira, VC; Saúde-Guimarães, DA; Simões-Silva, MR | 1 |
| Morilla, MJ; Romero, EL | 1 |
| Branquinho, RT; de Mello, CG; Lana, Md; Milagre, MM; Mosqueira, VC; Oliveira, MT; Saúde-Guimarães, DA | 1 |
1 review(s) available for azomycin and lychnopholide
| Article | Year |
|---|---|
Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis.
Topics: Animals; Chagas Disease; Humans; Lactones; Nanocapsules; Nanomedicine; Nitroimidazoles; Sesquiterpenes; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
2 other study(ies) available for azomycin and lychnopholide
| Article | Year |
|---|---|
Sesquiterpene lactone in nanostructured parenteral dosage form is efficacious in experimental Chagas disease.
Topics: Animals; Chagas Disease; Disease Models, Animal; Female; Lactones; Mice; Nanocapsules; Nitroimidazoles; Sesquiterpenes; Trypanosoma cruzi | 2014 |
Efficacy of Lychnopholide Polymeric Nanocapsules after Oral and Intravenous Administration in Murine Experimental Chagas Disease.
Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Animals; Chagas Disease; Chronic Disease; Delayed-Action Preparations; Disease Models, Animal; Drug Compounding; Humans; Lactones; Mice; Nanocapsules; Nitroimidazoles; Polyethylene Glycols; Sesquiterpenes; Survival Analysis; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi | 2016 |